Skip to main content
TipRanks
Go Ultimate75% OFF

Ronald Wooten Insider Profile

4 Followers

Ronald Wooten, former Director, Ten Percent Owner at Revance Therapeutics, holds 5.00 shares in Aceragen (Ticker: ACGN), holds 3.10M shares in Revance Therapeutics (Ticker: RVNC).

Ronald Wooten's Trading History

ACGN
Aceragen
Sep 30, 2022―Uninformative Buy―$1.90
RVNC
Revance Therapeutics
Feb 11, 2014―Uninformative Buy―$11.30M

You May Also Like

Ronald Wooten insider profile FAQ

What stocks does Ronald Wooten hold?
Ronald Wooten holds: RVNC, ACGN stocks.
What is Ronald Wooten's role in Revance Therapeutics?
Ronald Wooten's role in Revance Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.